Cellares, the first Integrated Development and Manufacturing Organization (IDMO), proudly announces that its Cell Shuttle™ ...

As of December 31, 2024, Fortress' consolidated cash and cash equivalents totaled $57.3 million, compared to $58.9 million as ...

The FDA has approved AstraZeneca's Imfinzi with gemcitabine and cisplatin as neoadjuvant treatment in adults with MIBC.

Non-profit organisations provide an alternative to rescue stalled orphan drugs for biotechs struggling against a lethargic ...

The approval follows the December 2024 priority review designation for this perioperative immunotherapy regimen for patients fighting muscle-invasive bladder cancer (MIBC).

OS Therapies Inc. (NYSE-A: OSTX) ("OS Therapies" or "the Company"), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today reported full-year 2024 financial ...

A centre dedicated to advocacy for children should be created as part of a re-examination of the Children Act 1998 that was ...

Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...

Going out to eat? See which Alachua County restaurants were rated best by inspectors, and which failed the test.

Going out to eat? See which Martin County restaurants were rated best by inspectors, and which failed the test.

Going out to eat? See which St. Lucie County restaurants were rated best by inspectors, and which failed the test.

A smattering of new features arrive across devices as Cupertino continues the slow and steady release of its flagship AI ...